No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Shares in American consumer health products group Kenvue were surging on Monday morning on reports that activist investor Starboard Value has amassed a "sizeable stake" in the company.
According to the Wall Street Journal, Starboard wants to boost the share price of Kenvue, which has underperformed the wider sector since the start of 2024.
The report, citing people familiar with the matter, suggested Starboard would push Kenvue's management to "make changes", but did not specify what the investment firm had in mind.
The size of the stake was not disclosed, but Starboard chief executive Jeff Smith is expected to appear at the 13D Monitor Active-Passive Investor Summit in New York on Tuesday and could unveil details there, the WSJ reported.
Tylenol and Aveeno maker Kenvue, the former consumer healthcare arm of Johnson & Johnson that was spun out in 2023, was trading 6.4% higher at $23.11 by 0944 ET.
As of Friday's closing price of $21.72, the stock had barely changed since the start of the year, compared with a 23% gain on the S&P 500.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.